NEOPROL

Intravenous Induction and Maintenance of Anesthesia

Startup

NEOPROL is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2014. Intravenous Induction and Maintenance of Anesthesia. Key investors include Integra Holdings. The company has 1-10 employees. Core technologies: Materials & Substances, Nanomaterials.

The company follows a B2B business model. Product stage: R&D.

1
Rounds
1
Investors
2
Team
2014
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMaterials & SubstancesNanomaterials
At a Glance
Investors
Frequently Asked Questions
What does NEOPROL do?

NEOPROL is the developer of a new formulation for anesthesia drugs. The companys NP-09 is an advanced preclinical development of an improved formulation and novel bioequivalent of propofol, with proven superiority over Diprivan. NEOPROLs formulation is based on an invention by Professor Nissim Garti.

What sector is NEOPROL in?

NEOPROL operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Materials & Substances, Nanomaterials. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Healthcare, Providers.

Where is NEOPROL located?

NEOPROL is based in Givat Ram, Jerusalem, Israel, Jerusalem District.

View Full Profile Classic View Website ↗